Ftse Mib
34.186,18
0,07%
DAX
19.909,14
-0,25%
S&P 500
5.914,90
0,13%
NASDAQ
19.492,09
0,03%
Bitcoin
95.383,11
2,94%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ HCW Biologics Inc (HCWB) HCW Biologics Inc (HCWB) Notizie

HCW Biologics Inc

HCWB
0,45
0,0165 (3,81%)
Ultimo aggiornamento: 16:20:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202414:30EDGAR2Form 8-K - Current report
23/12/202414:10GLOBEHCW Biologics Inc. Received NASDAQ Staff Determination..
05/12/202422:37EDGAR2Form D - Notice of Exempt Offering of Securities
22/11/202422:53EDGAR2Form SC 13D/A - General Statement of Acquisition of..
22/11/202422:45EDGAR2Form 8-K - Current report
20/11/202422:42EDGAR2Form 8-K - Current report
20/11/202418:54EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
19/11/202403:27GLOBEHCW Biologics Announces Pricing of $6.9 Million Registered..
18/11/202413:00GLOBEHCW Biologics and WY Biotech Announce License Agreement for..
18/11/202413:00EDGAR2Form 8-K - Current report
14/11/202423:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202423:13EDGAR2Form 8-K - Current report
14/11/202422:40GLOBEHCW Biologics Reports Third Quarter 2024 Financial Results..
20/9/202423:25EDGAR2Form 8-K - Current report
23/8/202422:35EDGAR2Form 8-K/A - Current report: [Amend]
23/8/202422:30GLOBEHCW Biologics Reports Second Quarter 2024 Financial Results..
14/8/202422:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:40EDGAR2Form 8-K - Current report
14/8/202422:35GLOBEHCW Biologics Reports Second Quarter 2024 Financial Results..
12/8/202422:35EDGAR2Form 8-K - Current report
18/7/202413:00EDGAR2Form 8-K - Current report
17/6/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202422:33EDGAR2Form 8-K - Current report
15/5/202423:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202422:45EDGAR2Form 8-K - Current report
15/5/202422:39GLOBEHCW Biologics Reports First Quarter 2024 Financial Results..
15/5/202422:35EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
01/4/202422:10GLOBEHCW Biologics Reports Fourth Quarter 2023 and Fiscal Year..
22/2/202420:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202420:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202420:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202414:39EDGAR2Form 8-K - Current report
12/1/202413:30EDGAR2Form 8-K - Current report
Apertura: 0,42 Min: 0,42 Max: 0,46999
Chiusura: 0,4335

La tua Cronologia

NASDAQ
HCWB
HCW Biologics
ASE
EUROBE
Eurobank Ergasias
BIT
SALVS5
Societe Generale Effekten
BIT
P1ILH6
BNP Paribas Issuance
BIT
S29240
Societe Generale Effekten
LSE
BIOT
L&g Pharma
NASDAQ
ABLLL
Abacus Life
BIT
P122L4
BNP PARIBAS ISSUANCE
AQSE
VUAG.GB
Vanguard Funds
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network